Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 4;12(3):630.
doi: 10.3390/diagnostics12030630.

Preoperative Apparent Diffusion Coefficient Values for Differentiation between Low and High Grade Meningiomas: An Updated Systematic Review and Meta-Analysis

Affiliations
Review

Preoperative Apparent Diffusion Coefficient Values for Differentiation between Low and High Grade Meningiomas: An Updated Systematic Review and Meta-Analysis

Yueh-Ting Tsai et al. Diagnostics (Basel). .

Abstract

The meta-analysis aimed to compare the preoperative apparent diffusion coefficient (ADC) values between low-grade meningiomas (LGMs) and high-grade meningiomas (HGMs). Medline, Cochrane, Scopus, and Embase databases were screened up to January 2022 for studies investigating the ADC values of meningiomas. The study endpoint was the reported ADC values for LGMs and HGMs. Further subgroup analyses between 1.5T and 3T MRI scanners, ADC threshold values, ADC in different histological LGMs, and correlation coefficients (r) between ADC and Ki-67 were also performed. The quality of studies was evaluated by the quality assessment of diagnostic accuracy studies (QUADAS-2). A χ2-based test of homogeneity was performed using Cochran’s Q statistic and inconsistency index (I2). Twenty-five studies with a total of 1552 meningiomas (1102 LGMs and 450 HGMs) were included. The mean ADC values (×10−3 mm2/s) were 0.92 and 0.79 for LGMs and HGMs, respectively. Compared with LGMs, significantly lower mean ADC values for HGMs were observed with a pooled difference of 0.13 (p < 0.00001). The results were consistent in both 1.5T and 3T MRI scanners. For ADC threshold values, pooled sensitivity of 69%, specificity of 82%, and AUC of 0.84 are obtained for differentiation between LGMs and HGMs. The mean ADC (×10−3 mm2/s) in different histological LGMs ranged from 0.87 to 1.22. Correlation coefficients (r) of mean ADC and Ki-67 ranged from −0.29 to −0.61. Preoperative ADC values are a useful tool for differentiating between LGMs and HGMs. Results of this study provide valuable information for planning treatments in meningiomas.

Keywords: ADC; DWI; MRI; meningioma; meta-analysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flowchart for study selection.
Figure 2
Figure 2
Forest plot for the pooled difference in mean ADC values between LGMs and HGMs. The pooled difference in mean ADC was 0.13 (95% CI = 0.08 to 0.17, p < 0.00001).
Figure 3
Figure 3
Forest plot for the pooled differences in mean ADC values between LGMs and HGMs in (a) 1.5T and (b) 3T MRI scanners. The pooled differences were 0.16 and 0.08, respectively (p < 0.001).
Figure 4
Figure 4
The (a) forest plot and (b) summary ROC curve in diagnostic test accuracy of ADC threshold values for differentiation between LGMs and HGMs. Pooled sensitivity of 69%, specificity of 82%, and AUC of 0.84 are obtained.

Similar articles

Cited by

References

    1. Ostrom Q.T., Patil N., Cioffi G., Waite K., Kruchko C., Barnholtz-Sloan J.S. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013–2017. Neuro Oncol. 2020;22:iv1–iv96. doi: 10.1093/neuonc/noaa200. - DOI - PMC - PubMed
    1. Louis D.N., Perry A., Reifenberger G., von Deimling A., Figarella-Branger D., Cavenee W.K., Ohgaki H., Wiestler O.D., Kleihues P., Ellison D.W. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A summary. Acta Neuropathol. 2016;131:803–820. doi: 10.1007/s00401-016-1545-1. - DOI - PubMed
    1. Durand A., Labrousse F., Jouvet A., Bauchet L., Kalamarides M., Menei P., Deruty R., Moreau J.J., Fevre-Montange M., Guyotat J. WHO grade II and III meningiomas: A study of prognostic factors. J. Neurooncol. 2009;95:367–375. doi: 10.1007/s11060-009-9934-0. - DOI - PubMed
    1. van Alkemade H., de Leau M., Dieleman E.M.T., Kardaun J.W.P.F., van Os R., Vandertop W.P., van Furth W.R., Stalpers L.J.A. Impaired survival and long-term neurological problems in benign meningioma. Neuro-Oncology. 2012;14:658–666. doi: 10.1093/neuonc/nos013. - DOI - PMC - PubMed
    1. Buerki R.A., Horbinski C.M., Kruser T., Horowitz P.M., James C.D., Lukas R.V. An overview of meningiomas. Future Oncol. 2018;14:2161–2177. doi: 10.2217/fon-2018-0006. - DOI - PMC - PubMed

LinkOut - more resources